This is a concern, and perhaps the most important thing we can do about it is make sure the FDA require a solid REMS program (https://www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems) that mandates that treatments follow similar safety guidelines that are being used in clinical research (e.g., https://www.researchgate.net/publication/5259182_Human_Hallucinogen_Research_Guidelines_for_Safety ). Another thing we need to do it always acknowledge and address mitigation strategies for risks when interfacing with the public or other scientists. Many will not do this, so it is on us who recognize the risks and their implications for leveraging these treatments to help the greatest number of people to keep awareness of them in public discourse.
This is a concern, and perhaps the most important thing we can do about it is make sure the FDA require a solid REMS program (https://www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems) that mandates that treatments follow similar safety guidelines that are being used in clinical research (e.g., https://www.researchgate.net/publication/5259182_Human_Hallucinogen_Research_Guidelines_for_Safety ). Another thing we need to do it always acknowledge and address mitigation strategies for risks when interfacing with the public or other scientists. Many will not do this, so it is on us who recognize the risks and their implications for leveraging these treatments to help the greatest number of people to keep awareness of them in public discourse.